America’s Blood Centers (ABC) has published its 2025 blood Advocacy Agenda. The federal legislative and regulatory priorities that are most important to community blood centers are reflected within the ABC 2025 blood Advocacy Agenda which includes clearly defined legislative and regulatory solutions. The 2025 blood Advocacy Agenda has been developed in consultation with the ABC Board of Directors, Policy Council, and input from member blood centers. It will guide the work of the association on behalf of its member blood centers as ABC continues to urge the Trump Administration, Congress, and industry stakeholders to promote the value of blood to patients, communities, and the healthcare system by:
- “urging the U.S. Food and Drug Administration (FDA) to update the licensure process to allow blood centers to quickly and safely meet the changing demands for blood components for patients;
- exempt[ing] laboratory developed tests (LDTs) used by blood centers from reforms to diagnostics regulation;
- updating the payment policy for federal insurance programs to provide sufficient reimbursement to allow for broader adoption of prehospital blood transfusions;
- providing increased support and resources to blood centers to update their current information technology (IT) infrastructures and strengthen their ability to prevent potential attacks;
- supporting a robust donor base by prioritizing blood donation as a national imperative;
- committing federal resources in support of the vital role of blood in the healthcare system; [and]
- reducing unnecessary and burdensome regulation to support innovation and blood product availability.”
ABC thanks its member blood centers and partners who have and continue to help advance the priorities and work of independent community blood centers.